Overview

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

Status:
Not yet recruiting

Trial end date:
2030-12-01

Target enrollment:

Participant gender:

Summary

This randomized, controlled clinical trial compares the perioperative treatment with acetylsalicylic acid (aspirin) in patients with cancer of the pancreatic head. The main question it aims to answer is: Do patients treated perioperatively with aspirin develop less metastasis after curative resection of pancreatic head tumors? Participants will be asked to : - take a daily aspirin tablet starting 1-4 weeks before surgery until 6 months after surgery - participate in regular follow-up visits (every three months in the first year after surgery, every six months in years 2 and 3 after surgery).

Phase:

Phase 3

Details

Lead Sponsor:

German Cancer Research Center

Treatments:

Aspirin